Canada markets closed

NOXXON Pharma N.V. (ALNOX.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
0.2392-0.0050 (-2.05%)
At close: 05:26PM CET
Currency in EUR

Valuation Measures4

Market Cap (intraday) 23.31M
Enterprise Value 9.65M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.37
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.04

Trading Information

Stock Price History

Beta (5Y Monthly) 2.01
52-Week Change 3-42.47%
S&P500 52-Week Change 316.48%
52 Week High 30.5360
52 Week Low 30.2100
50-Day Moving Average 30.2806
200-Day Moving Average 30.3283

Share Statistics

Avg Vol (3 month) 31.4M
Avg Vol (10 day) 3403.85k
Shares Outstanding 567.87M
Implied Shares Outstanding 6N/A
Float 870.53M
% Held by Insiders 10.00%
% Held by Institutions 17.82%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 31, 2020
Most Recent Quarter (mrq)Jun. 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-6,817.36%

Management Effectiveness

Return on Assets (ttm)-49.13%
Return on Equity (ttm)-123.56%

Income Statement

Revenue (ttm)144k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)330.30%
Gross Profit (ttm)35k
EBITDA -9.8M
Net Income Avi to Common (ttm)-11.24M
Diluted EPS (ttm)-0.2190
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)13.67M
Total Cash Per Share (mrq)0.19
Total Debt (mrq)45k
Total Debt/Equity (mrq)0.46
Current Ratio (mrq)3.30
Book Value Per Share (mrq)0.14

Cash Flow Statement

Operating Cash Flow (ttm)-9.34M
Levered Free Cash Flow (ttm)-4.28M